PARPi triggers STING-dependent immune response and enhances therapeutic efficacy of immune checkpoint blockade independent of BRCAness
Jianfeng Shen(The University of Texas MD Anderson Cancer Center), Guang Peng(The University of Texas MD Anderson Cancer Center)
Cited by 7
Related Papers
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors
|Journal of Clinical Investigation|2020|103
BAP1 inactivation promotes lactate production by leveraging the subcellular localization of LDHA in melanoma
|Cell Death Discovery|2024|6
PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites
|Advanced Science|2026|0